Sponsor Pipeline

Connect Biopharm LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06940154 Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) COPD Acute Exacerbation Active, Not Recruiting
NCT07705737 Rademikibart IV for Acute Asthma and COPD Exacerbation Asthma Acute Not Yet Recruiting
NCT06940141 Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) Asthma Acute Active, Not Recruiting
Disease Areas
Asthma (2) COPD (2)
Get alerts when Connect Biopharm LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free